Vaxxas CEO David Hoey said, “Our HD-MAP technology offers a potential solution to the growing need to significantly expand global access to innovative mRNA vaccines by eliminating the current ultra-cold storage requirements for these vaccines." …
CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines
January 23, 2025 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Report highlights international confidence in Australian clinical trials
May 19, 2025 - - Latest News -
Experts urge vigilance with RSV ahead of winter, saying it’s as serious in older adults as it is in babies
May 19, 2025 - - Latest News -
FDA clears the first blood test used for diagnosing Alzheimer’s Disease
May 19, 2025 - - Latest News -
Lilly Australia taking the time to prioritise wellbeing
May 18, 2025 - - Latest News -
New report reveals the magnitude of the challenge facing Mark Butler
May 18, 2025 - - Latest News -
We need to be honest about the fact our governments ruthlessly dictate the terms of care
May 17, 2025 - - Latest News -
Applications now open for Moderna MRNA-focused research program
May 15, 2025 - - Latest News